New drug BOS-580 tested for fatty liver disease – results pending
Disease control
Completed
This study tested a new drug called BOS-580 in 231 obese adults who either had or were at risk for a serious liver condition called NASH. The main goal was to check if the drug is safe and tolerable. Participants received either the drug or a placebo, and some later joined an ope…
Phase: PHASE2 • Sponsor: Boston Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:53 UTC